ITGAX and metabolic dysfunction-associated steatohepatitis: In addition, we have identified evidence that CD11c−/Ly6C+ cells, which differ in their localization in the liver from CD11c+/Ly6C− cells, are implicated in the pathogenesis of anti-inflammation/tissue repair in NASH.